Snowball logo
logo
MOB_logo

Moberg Pharma AB (publ)

MOB ST
SEK 10.94-SEK 0.46  (4.04%)
Estimate
EPS
-0.55
Beta
0.636
Growth
Revenue, YoY
27.24%
Net income, YoY
54.4%
FCF, YoY
66.5%
Forecast
P/E (FWD)
54.7
EPS (FWD)
0.2
About the company
Ticker
MOB
ISIN
SE0003613090
Country
Sweden
Sector (GICS)
Healthcare
Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products primarily in Sweden. It offers MOB-015 for the treatment of nail fungus under the Terclara brand. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013. It has license agreement with Karo Healthcare for distribution in European market. Moberg Pharma AB (publ) was incorporated in 2006 and is based in Bromma, Sweden.

Frequently asked questions

What sector does Moberg Pharma AB (publ) (MOB) operate in?

Moberg Pharma AB (publ) belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Moberg Pharma AB (publ) (MOB) current stock price?

As of the latest data, Moberg Pharma AB (publ) stock price is SEK 10.94, with a previous close of SEK 11.40. Moberg Pharma AB (publ) lost -SEK 0.46 in the last trading session, representing a -4.04% loss.

What is Moberg Pharma AB (publ) (MOB) current market capitalization?

Moberg Pharma AB (publ) market cap is approximately 516.16 million.

What is Moberg Pharma AB (publ) (MOB) Earnings Per Share (EPS)?

The trailing EPS is -SEK 0.55, and the forward EPS is SEK 0.20.

What is Moberg Pharma AB (publ) (MOB) EBITDA?

Moberg Pharma AB (publ) EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -3.98 million.

Does Moberg Pharma AB (publ) (MOB) pay dividends?

No. Moberg Pharma AB (publ) does not pay a dividend.

What is Moberg Pharma AB (publ) (MOB) beta (volatility) score?

Moberg Pharma AB (publ) has a beta of 0.636, indicating lower volatility than the overall market.